Kitov Pharmaceuticals Ltd.
🇮🇱Israel
Clinical Trials
3
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 3
1 (33.3%)Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Over-encapsulated 200 mg celecoxib capsuleDrug: Over-encapsulated 10 mg amlodipine besylate tabletDrug: Matched placebo capsule for over-encapsulated celecoxib capsuleDrug: Matched placebo capsule for over-encapsulated amlodipine besylate tablet
- First Posted Date
- 2014-06-24
- Last Posted Date
- 2018-10-10
- Lead Sponsor
- Kitov Pharmaceuticals, Ltd.
- Target Recruit Count
- 152
- Registration Number
- NCT02172040
- Locations
- 🇬🇧
Celerion, Belfast, Antrim, United Kingdom
🇬🇧The Medicines Evaluation Unit Ltd., Manchester, Greater Manchester, United Kingdom
🇬🇧Reading Clinical Research Aspect, Reading, United Kingdom
News
No news found